These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 30134206)

  • 1. Metal-organic frameworks, NH
    Kim SN; Park CG; Huh BK; Lee SH; Min CH; Lee YY; Kim YK; Park KH; Choy YB
    Acta Biomater; 2018 Oct; 79():344-353. PubMed ID: 30134206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine.
    Kim SN; Ko SA; Park CG; Lee SH; Huh BK; Park YH; Kim YK; Ha A; Park KH; Choy YB
    Mol Pharm; 2018 Aug; 15(8):3143-3152. PubMed ID: 30020792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug.
    Park CG; Kim YK; Kim MJ; Park M; Kim MH; Lee SH; Choi SY; Lee WS; Chung YJ; Jung YE; Park KH; Choy YB
    J Control Release; 2015 Dec; 220(Pt A):180-188. PubMed ID: 26478018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-Organic Frameworks as Drug Delivery Platforms for Ocular Therapeutics.
    Gandara-Loe J; Ortuño-Lizarán I; Fernández-Sanchez L; Alió JL; Cuenca N; Vega-Estrada A; Silvestre-Albero J
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1924-1931. PubMed ID: 30561189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brimonidine-montmorillonite hybrid formulation for topical drug delivery to the eye.
    Park CG; Choi G; Kim MH; Kim SN; Lee H; Lee NK; Choy YB; Choy JH
    J Mater Chem B; 2020 Sep; 8(35):7914-7920. PubMed ID: 32726382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.
    Emad Eldeeb A; Salah S; Ghorab M
    Drug Deliv; 2019 Dec; 26(1):509-521. PubMed ID: 31090464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
    Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment.
    Zhang Z; Ma Q; Dai Z; Hong J; Gu J; Shi R; Xu J; Ma Y; Sun X; Sun J
    Expert Opin Drug Deliv; 2024 Jun; 21(6):975-986. PubMed ID: 38975698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation.
    El-Salamouni NS; Farid RM; El-Kamel AH; El-Gamal SS
    J Microencapsul; 2018 Jan; 35(1):102-113. PubMed ID: 29310481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics.
    Gandara-Loe J; Souza BE; Missyul A; Giraldo G; Tan JC; Silvestre-Albero J
    ACS Appl Mater Interfaces; 2020 Jul; 12(27):30189-30197. PubMed ID: 32530261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
    Guo A; Durymanov M; Permyakova A; Sene S; Serre C; Reineke J
    Pharm Res; 2019 Feb; 36(4):53. PubMed ID: 30790066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    Aburahma MH; Mahmoud AA
    AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy.
    Cho IS; Park CG; Huh BK; Cho MO; Khatun Z; Li Z; Kang SW; Choy YB; Huh KM
    Acta Biomater; 2016 Jul; 39():124-132. PubMed ID: 27163401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device.
    Samy KE; Cao Y; Kim J; Konichi da Silva NR; Phone A; Bloomer MM; Bhisitkul RB; Desai TA
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):124-131. PubMed ID: 30615539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.
    Tripathi S; Yadav KS
    Daru; 2024 Jun; 32(1):161-175. PubMed ID: 38158475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient Fenton and enzyme-mimetic activities of NH
    He J; Zhang Y; Zhang X; Huang Y
    Sci Rep; 2018 Mar; 8(1):5159. PubMed ID: 29581533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controllable Synthesis of a Smart Multifunctional Nanoscale Metal-Organic Framework for Magnetic Resonance/Optical Imaging and Targeted Drug Delivery.
    Gao X; Zhai M; Guan W; Liu J; Liu Z; Damirin A
    ACS Appl Mater Interfaces; 2017 Feb; 9(4):3455-3462. PubMed ID: 28079361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.
    Chiang B; Kim YC; Doty AC; Grossniklaus HE; Schwendeman SP; Prausnitz MR
    J Control Release; 2016 Apr; 228():48-57. PubMed ID: 26930266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma.
    Zhao Y; Huang C; Zhang Z; Hong J; Xu J; Sun X; Sun J
    Drug Deliv; 2022 Dec; 29(1):613-623. PubMed ID: 35174743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits.
    Pang X; Li J; Pi J; Qi D; Guo P; Li N; Wu Y; Liu Z
    Pharm Dev Technol; 2018 Mar; 23(3):231-239. PubMed ID: 28488447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.